Buy high quality N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor from Chemicea Pharma. Chemicea Pharma is one of the leading manufacturer and exporter of N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor
N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor
CAT. No.
CP-T21273
CAS. No.
NA
Mol. F.
C23H26F2N8O6S
Mol. Wt.
580.57
Stock Status
Custom Synthesis
Category:
Impurity Standards
Synonyms:
NA
Chemical Name:
N-(3-(3,4-difluorophenyl)-4,5-dihydroisoxazol-5-yl)-N-(3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)nitrous amide
Request for Quotation : N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor
Search by Keywords - Buy N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor | Purchase N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor | Order N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor | Enquire N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor | Price of N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor | N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor Cost | N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor Supplier | N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor Distributor | N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor Manufacturer | N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor Exporter | N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor for Method Validation | N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor for ANDA Filing | N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor for Forced Degradation Studies | N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor Identification Standards | N-Nitroso 4,5-Dihydroisoxazole Derivative of Ticagrelor for DMF Filing | Ticagrelor
We have received your request successfully. Thank you for your interest in our product line. To
provide you with a Quotation, Our Sales team will contact you shortly.
Chemicea Pharmaceuticals Pvt. Ltd.
Thank You
You will receive blog content, featuring scientific research and exclusive promotions.